Clinical Trial Update: Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating stereotactic body radiation therapy with FES PET/CT imaging for oligoprogressive estrogen receptor–positive metastatic breast cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: City of Hope Medical Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma | Phase 2 | Status: RECRUITING